Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Jann

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
The American Journal of Psychiatry|May 1, 1982
Lithium prophylaxis of tricyclic-antidepressant-induced mania in bipolar patientsM W Jann, A H Bitar, A Rao
Clinical Pharmacokinetics|July 1, 1985
Clinical pharmacokinetics of the depot antipsychoticsM W Jann, L Ereshefsky, S R Saklad
Pharmacotherapy|January 1, 1992
Therapeutic frontiers in Alzheimer's diseaseS W Miller, J M Mahoney, M W Jann
Psychopharmacology|January 1, 1990
Reversible metabolism of haloperidol and reduced haloperidol in Chinese schizophrenic patientsM W Jann, Y W Lam, W H Chang
Journal of Clinical Psychopharmacology|January 5, 2002
Differences in haloperidol epidemiologic pharmacokinetic studiesM W Jann, W H Chang, H Y Lane
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1994
Rapid formation of clozapine in guinea-pigs and man following clozapine-N-oxide administrationM W Jann, Y W Lam, W H Chang
The Annals of Pharmacotherapy|January 12, 2000
Comment: significant interactions with new antiretrovirals and psychotropic drugsS R Penzak, S R Grimsley, M W Jann
Clinical Pharmacy|July 1, 1985
Use of carbamazepine in psychiatric disordersL J Birkhimer, J L Curtis, M W Jann
Journal of Clinical Psychopharmacology|April 1, 1991
Interconversions between haloperidol and reduced haloperidol in schizophrenic patients and guinea pigs: a steady-state studyW H Chang, S K Lin, M W Jann
Pharmacotherapy|May 1, 1997
Venlafaxine and nefazodone, two pharmacologically distinct antidepressantsB G Augustin, J A Cold, M W Jann
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
The American Journal of Psychiatry|May 1, 1982
Lithium prophylaxis of tricyclic-antidepressant-induced mania in bipolar patientsM W Jann, A H Bitar, A Rao
Clinical Pharmacokinetics|July 1, 1985
Clinical pharmacokinetics of the depot antipsychoticsM W Jann, L Ereshefsky, S R Saklad
Pharmacotherapy|January 1, 1992
Therapeutic frontiers in Alzheimer's diseaseS W Miller, J M Mahoney, M W Jann
Psychopharmacology|January 1, 1990
Reversible metabolism of haloperidol and reduced haloperidol in Chinese schizophrenic patientsM W Jann, Y W Lam, W H Chang
Journal of Clinical Psychopharmacology|January 5, 2002
Differences in haloperidol epidemiologic pharmacokinetic studiesM W Jann, W H Chang, H Y Lane
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1994
Rapid formation of clozapine in guinea-pigs and man following clozapine-N-oxide administrationM W Jann, Y W Lam, W H Chang
The Annals of Pharmacotherapy|January 12, 2000
Comment: significant interactions with new antiretrovirals and psychotropic drugsS R Penzak, S R Grimsley, M W Jann
Clinical Pharmacy|July 1, 1985
Use of carbamazepine in psychiatric disordersL J Birkhimer, J L Curtis, M W Jann
Journal of Clinical Psychopharmacology|April 1, 1991
Interconversions between haloperidol and reduced haloperidol in schizophrenic patients and guinea pigs: a steady-state studyW H Chang, S K Lin, M W Jann
Pharmacotherapy|May 1, 1997
Venlafaxine and nefazodone, two pharmacologically distinct antidepressantsB G Augustin, J A Cold, M W Jann
Pageof 10